FDA Adverse Event Malfunction Summary report: N

COBAS C 503 ANALYTICAL UNIT

MDR report key: 19655570 · Received July 2, 2024

Report

Report Number
1823260-2024-01916
Event Type
Malfunction
Date Received
July 2, 2024
Date of Event
June 11, 2024
Report Date
September 4, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K191899
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

GENERAL REAGENT ISSUES COULD BE EXCLUDED AS QC AND CALIBRATION WERE INCONSPICUOUS. THE FIELD SERVICE ENGINEER REPLACED THE SYRINGE UNIT AND RINSE TUBING. HE CHECKED AND ADJUSTED THE SAMPLE PROBE. AFTER THE SERVICE ACTIONS, THE INSTRUMENT PERFORMED AS SPECIFIED. THE INVESTIGATION DETERMINED THAT THE SERVICE ACTIONS RESOLVED THE ISSUE.

Additional Manufacturer Narrative · 0

THE GLUCOSE REAGENT LOT NUMBER WAS 747661. THE CREATININE REAGENT LOT NUMBER WAS 772926. THE UREA REAGENT LOT NUMBER WAS 790818. THE EXPIRATION DATES WERE NOT PROVIDED. THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF QUESTIONABLE RESULTS FOR TWO PATIENTS FROM THE COBAS C 503 ANALYTICAL UNIT. PATIENT 1 INITIAL GLUCOSE HK GEN.3 RESULT WAS 15.4 MG/DL WITH A DATA FLAG. THE AUTOMATIC REPEAT RESULT WAS 108 MG/DL. PATIENT 2 INITIAL COBAS CREATININE PLUS VER.2 ASSAY RESULT WAS 0.253 MG/DL. THE MANUAL REPEAT RESULT WAS 2.22 MG/DL. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. ON 28-JUN-2024, PATIENT 3 INITIAL UREA RESULT WAS 7.15 MG/DL WITH A DATA FLAG. THE REPEAT RESULT WAS 47.7 MG/DL. THE QUESTIONABLE RESULT FOR THIS SAMPLE WAS REPORTED OUTSIDE THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
801690 COBAS C 503 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown